CDC Statement on Results from RTS,S/AS01 Malaria Vaccine Trial
The Centers for Disease Control and Prevention welcomes the announcement today that results from the clinical trial in Africa of a malaria vaccine candidate show it prevented about half of malaria cases, including the most severe, in young children.
The RTS,S/AS01 study results, published in the New England Journal of Medicine, are a promising advance in development of a malaria vaccine for African children, which, if successful, could save hundreds of thousands of lives. In 2009, malaria caused the deaths of nearly 800,000 people; approximately 90 percent were children in Africa. >>Learn more
Modify/Update Subscriber Preferences | Unsubscribe | Send Feedback | Learn more about CDC Email Updates
To receive the latest news for your region, please update your profile with your country, state and zip code.
Questions or problems? Please contact support@govdelivery.com.
 |
|  |
| STAY CONNECTED: | |||||||||||||||
 | CDC on Facebook |  | CDC on Twitter |  | CDC on YouTube | ||||||||||
Centers for Disease Control and Prevention (CDC) · 1600 Clifton Rd · Atlanta GA 30333 · 800-CDC-INFO (800-232-4636)
No comments:
Post a Comment